Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

microvision - MVIS

MVIS

Close Chg Chg %
0.85 -0.02 -2.29%

Closed Market

0.83

-0.02 (2.29%)

Volume: 6.06M

Last Updated:

Dec 31, 2025, 4:00 PM EDT

Trade Now

Company Overview: microvision - MVIS

MVIS Key Data

Open

$0.86

 Day Range

0.82 - 0.86

52 Week Range

0.81 - 1.95

 Market Cap

$253.48M

Shares Outstanding

305.40M

 Public Float

301.48M

Beta

1.27

 Rev. Per Employee

N/A

P/E Ratio

N/A

 EPS

-$0.37

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

5.06M

  

MVIS Performance

1 Week
 
 -9.08%
 
1 Month
 
 -9.69%
 
3 Months
 
 -41.68%
 
1 Year
 
 -36.79%
 
5 Years
 
 -84.61%
 

MVIS Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 2
Full Ratings ➔

About microvision - MVIS

MicroVision, Inc. engages in the development of laser beam scanning technology. The company integrates micro-electrical mechanical systems, lasers, optics, hardware, algorithms and machine learning software into its proprietary technology to address existing and emerging markets. It also develops automotive lidar sensors and provides solutions for advanced driver-assistance systems, autonomous vehicles, and non-automotive applications. The company was founded in May 1993 and is headquartered in Redmond, WA.

MVIS At a Glance

MicroVision, Inc.
18390 NE 68th Street
Redmond, Washington 98052
Phone 1-425-936-6847 Revenue 4.70M
Industry Semiconductors Net Income -96,915,000.00
Sector Electronic Technology Employees 185
Fiscal Year-end 12 / 2025
View SEC Filings

MVIS Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 58.445
Price to Book Ratio 6.044
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -3.381
Enterprise Value to Sales 53.478
Total Debt to Enterprise Value 0.206

MVIS Efficiency

Revenue/Employee 25,383.784
Income Per Employee -523,864.865
Receivables Turnover 5.071
Total Asset Turnover 0.037

MVIS Liquidity

Current Ratio 1.795
Quick Ratio 1.745
Cash Ratio 1.631

MVIS Profitability

Gross Margin -207.709
Operating Margin -1,729.025
Pretax Margin -2,052.981
Net Margin -2,063.778
Return on Assets -77.286
Return on Equity -134.071
Return on Total Capital -96.522
Return on Invested Capital -106.503

MVIS Capital Structure

Total Debt to Total Equity 105.883
Total Debt to Total Capital 51.429
Total Debt to Total Assets 42.619
Long-Term Debt to Equity 50.663
Long-Term Debt to Total Capital 24.608
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Microvision - MVIS

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
2.50M 664.00K 7.26M 4.70M
Sales Growth
-19.09% -73.44% +993.22% -35.31%
Cost of Goods Sold (COGS) incl D&A
1.47M 2.35M 10.64M 14.45M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
1.46M 2.25M 7.86M 6.92M
Depreciation
1.42M 2.21M 5.76M 4.82M
Amortization of Intangibles
49.00K 40.00K 2.10M 2.10M
COGS Growth
+4.86% +60.03% +353.37% +35.86%
Gross Income
1.03M (1.68M) (3.38M) (9.75M)
Gross Income Growth
-38.89% -262.67% -100.77% -188.84%
Gross Profit Margin
+41.36% -253.31% -46.52% -207.71%
2021 2022 2023 2024 5-year trend
SG&A Expense
44.90M 52.21M 85.53M 71.44M
Research & Development
24.11M 30.41M 56.71M 49.02M
Other SG&A
20.79M 21.80M 28.82M 22.43M
SGA Growth
+184.97% +16.27% +63.83% -16.47%
Other Operating Expense
- - - -
-
Unusual Expense
- - (692.00K) 13.05M
-
EBIT after Unusual Expense
(43.18M) (53.89M) (88.91M) (94.24M)
Non Operating Income/Expense
(23.00K) 799.00K 7.21M 2.29M
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
- - - 4.46M
-
Interest Expense Growth
- - - -
-
Gross Interest Expense
- - - 4.46M
-
Interest Capitalized
- - - -
-
Pretax Income
(43.20M) (53.09M) (81.70M) (96.41M)
Pretax Income Growth
-216.85% -22.90% -53.88% -18.01%
Pretax Margin
-1,728.00% -7,995.63% -1,125.44% -2,052.98%
Income Tax
- - 1.15M 507.00K
-
Income Tax - Current - Domestic
- - - -
-
Income Tax - Current - Foreign
- - 2.06M 581.00K
-
Income Tax - Deferred - Domestic
- - - -
-
Income Tax - Deferred - Foreign
- - (915.00K) (74.00K)
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(43.20M) (53.09M) (82.84M) (96.92M)
Minority Interest Expense
- - - -
-
Net Income
(43.20M) (53.09M) (82.84M) (96.92M)
Net Income Growth
-216.85% -22.90% -56.04% -16.99%
Net Margin Growth
-1,728.00% -7,995.63% -1,141.23% -2,063.78%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(43.20M) (53.09M) (82.84M) (96.92M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(43.20M) (53.09M) (82.84M) (96.92M)
EPS (Basic)
-0.2689 -0.3199 -0.4532 -0.4626
EPS (Basic) Growth
-175.79% -18.97% -41.67% -2.07%
Basic Shares Outstanding
160.66M 165.96M 182.80M 209.51M
EPS (Diluted)
-0.2689 -0.3199 -0.4532 -0.4626
EPS (Diluted) Growth
-175.79% -18.97% -41.67% -2.07%
Diluted Shares Outstanding
160.66M 165.96M 182.80M 209.51M
EBITDA
(42.41M) (51.64M) (81.05M) (74.28M)
EBITDA Growth
-223.65% -21.79% -56.93% +8.35%
EBITDA Margin
-1,696.20% -7,777.71% -1,116.48% -1,581.67%

Snapshot

Average Recommendation BUY Average Target Price 2.50
Number of Ratings 2 Current Quarters Estimate -0.04
FY Report Date 03 / 2026 Current Year's Estimate -0.16
Last Quarter’s Earnings -0.05 Median PE on CY Estimate N/A
Year Ago Earnings -0.245 Next Fiscal Year Estimate -0.135
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 2 2 2 2
Mean Estimate -0.04 -0.04 -0.16 -0.14
High Estimates -0.03 -0.03 -0.13 -0.11
Low Estimate -0.05 -0.05 -0.19 -0.16
Coefficient of Variance -34.48 -38.73 -26.52 -26.19

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 2 2 2
OVERWEIGHT 0 0 0
HOLD 0 0 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Insider Actions for Microvision - MVIS

Date Name Shares Transaction Value
Jul 29, 2025 Sumit Sharma CEO; Director 1,273,421 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jul 29, 2025 Sumit Sharma CEO; Director 1,644,671 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jul 29, 2025 Sumit Sharma CEO; Director 1,302,740 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $1.32 per share 1,719,616.80
Jul 29, 2025 Sumit Sharma CEO; Director 375,000 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jul 29, 2025 Sumit Sharma CEO; Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jul 29, 2025 Sumit Sharma CEO; Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 10, 2025 Jeffrey A Herbst Director 164,706 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 10, 2025 Jeffrey A Herbst Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 10, 2025 Jeffrey A Herbst Director 87,642 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jun 10, 2025 Peter Schabert Director 80,450 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 10, 2025 Peter Schabert Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 10, 2025 Peter Schabert Director 87,642 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jun 10, 2025 Jada Smith Director 60,337 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 10, 2025 Jada Smith Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Jun 10, 2025 Jada Smith Director 87,642 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 4, 2025 Glen W. DeVos SVP, Chief Technology Officer 1,300,000 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Microvision in the News